Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
MINNEAPOLIS, April 09, 2018 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that first quarter 2018 financial results will be released after the market closes on Monday, May 7.
Management will host a conference call at 5:00 p.m. Eastern Time on May 7 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may dial 833-286-5804 (647-689-4449 for international callers) and provide access code 8265599. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 800-585-8367 (416-621-4642 for international callers); access code 8265599. The webcast will be archived at investors.tactilemedical.com.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
Investor Inquiries: Mike Piccinino, CFA Managing Director Westwicke Partners 443-213-0500 [email protected]
